Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia
Male
0301 basic medicine
Period (music)
[SDV]Life Sciences [q-bio]
MESH: Spike Glycoprotein, Coronavirus
Evolutionary biology
Infectious disease (medical specialty)
MESH: Base Sequence
FOS: Health sciences
spike protein
Gene
Genetic diversity
Agricultural and Biological Sciences
Computational biology
MESH: Aged, 80 and over
COVID-19 Testing
Sociology
MESH: Child
Pathology
MESH: COVID-19
Disease
DNA sequencing
MESH: Phylogeny
Child
MESH: High-Throughput Nucleotide Sequencing
Phylogeny
MESH: Aged
Aged, 80 and over
MESH: Middle Aged
Genome
Physics
High-Throughput Nucleotide Sequencing
Life Sciences
Middle Aged
QR1-502
FOS: Sociology
3. Good health
Infectious Diseases
MESH: Young Adult
whole-genome sequencing
Child, Preschool
VOIs
Spike Glycoprotein, Coronavirus
Telecommunications
Medicine
Female
MESH: Genome, Viral
MESH: Tunisia
MESH: Whole Genome Sequencing
Research Article
Adult
Tunisia
MESH: Mutation
Adolescent
Population
Genome, Viral
Coronavirus Disease 2019 Research
Serogroup
Microbiology
03 medical and health sciences
Virology
Health Sciences
Genetics
Humans
MESH: SARS-CoV-2
Viral Diseases in Livestock and Poultry
Biology
Aged
Demography
MESH: Adolescent
Genomic Sequencing
MESH: Humans
Base Sequence
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
MESH: Child, Preschool
MESH: COVID-19 Testing
VOCs
COVID-19
Gastrointestinal Viral Infections and Vaccines Development
MESH: Adult
Outbreak
MESH: Serogroup
Acoustics
Transmission (telecommunications)
Computer science
MESH: Male
Coronavirus disease 2019 (COVID-19)
Whole genome sequencing
FOS: Biological sciences
Mutation
Animal Science and Zoology
MESH: Female
2019-20 coronavirus outbreak
DOI:
10.1128/spectrum.00639-21
Publication Date:
2021-11-10T15:31:46Z
AUTHORS (15)
ABSTRACT
The method of choice for SARS-CoV-2 variant detection is whole-genome sequencing using next-generation sequencing (NGS) technologies. Resources for this technology remain limited in many low- and middle-income countries, where it is not possible to perform whole-genome sequencing for representative numbers of SARS-CoV-2-positive cases.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (38)
CITATIONS (9)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....